Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.

Cumulative Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Anastrozole, Raloxifene). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the pct-agent safety flag (Anastrozole, Raloxifene). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Anastrozole, Raloxifene). Monitor accordingly.
+
Anastrozole + Raloxifene
Compatible

Raloxifene and anastrozole work through complementary mechanisms. Anastrozole reduces estrogen production via aromatase inhibition, while raloxifene blocks estrogen receptor signaling in breast tissue. Unlike tamoxifen, raloxifene is not metabolized via CYP pathways, so anastrozole does not impair its efficacy. Can be used together when both aromatase inhibition and breast tissue protection are desired.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.